Business context and reporting period
Camtek Ltd. filed this audited Form 20-F for the fiscal year ended December 31, 2014—not a standalone 2014 fourth-quarter report. The company designs, manufactures and sells automated optical inspection (AOI) systems and functional ink technology products for semiconductor and printed-circuit-board (PCB) manufacturing. Financial statements are prepared under U.S. GAAP; amounts below are U.S. dollars.
Financial performance and liquidity
| Metric | FY 2014 | FY 2013 |
|---|---|---|
| Revenue | $88.3 million | $85.4 million |
| Gross profit / margin | $41.0 million / 46.4% | $34.4 million / 40.3% |
| Operating income / margin | $5.1 million / 5.8% | $1.1 million / 1.3% |
| Net income | $3.3 million | $7,000 |
| Basic and diluted EPS | $0.11 | $0.00 |
| Cash from operating activities | $6.0 million | $4.7 million |
| Cash and cash equivalents | $18.2 million | $16.5 million |
| Short-term deposits | $8.6 million | $6.0 million |
| Total assets / liabilities | $96.5 million / $30.8 million | $91.9 million / $30.0 million |
Working capital was $51.7 million, up from $47.1 million. Current assets of $77.6 million compared with current liabilities of $25.8 million. The company reported no bank loans outstanding at year-end. Capital expenditures were approximately $0.9 million; investing cash outflow was $3.3 million, largely reflecting investment in short-term deposits. Financing cash outflow was $0.3 million.
FY 2014 revenue comprised $71.4 million of product sales and $16.9 million of service fees. Semiconductor-segment revenue was $57.8 million, with segment operating income of $9.9 million; PCB-segment revenue was $30.5 million, with segment operating loss of $2.4 million. Segment figures precede corporate expenses and other reconciliation items.
Material changes versus the prior comparable period
- Revenue increased 3% year over year. Semiconductor revenue grew, including a 24% increase in AOI-related product revenue; PCB revenue declined about 4% and service fees declined 3%.
- Gross margin rose 6.1 percentage points, supported by product mix and lower inventory write-offs: approximately $0.5 million in 2014 versus $3.7 million in 2013.
- Operating income improved to $5.1 million from $1.1 million. Net income increased from near break-even, while 2013 included a $0.6 million income-tax benefit and a large favorable revaluation of Sela-related liabilities.
- Operating cash flow rose to $6.0 million. Lower receivables supported cash generation, partly offset by a $5.9 million increase in inventory.
- Microelectronics segment operating income rose to $9.9 million from $5.6 million; the PCB segment operating loss widened to $2.4 million from $1.6 million.
Outlook, management commentary, risks and unusual items
Management said industry improvement continued in 2014, driven in part by advanced packaging, and expected positive momentum to continue into 2015 despite global economic uncertainty. It gave no specific numerical revenue or earnings guidance. The Gryphon functional ink system completed beta testing at two customer sites and entered commercialization; the filing cautions that customer adoption, market penetration and returns on investment remain uncertain.
- Rudolph patent litigation: A February 2015 judgment awarded approximately $14.5 million, including interest, and reinstated an injunction affecting Falcon sales and marketing in the United States. Camtek appealed and posted a $15 million bond in March 2015, backed by a bank guarantee and approximately $7.9 million of restricted cash collateral, with a lien on its Israeli facility. The company recorded no accrual; it disclosed a possible loss range of $0–$14.5 million, excluding future interest and legal fees. It stated that existing resources and operating cash flows were expected to meet liquidity needs through 2015, while acknowledging the bond’s liquidity impact.
- Rudolph also has a stayed patent case involving the ’528 patent, and in March 2015 filed a separate, unquantified claim alleging the Eagle system infringes the ’298 patent. Camtek denies infringement. The outcome of these matters is uncertain.
- OCS grant dispute: Camtek disputed approximately $770,000 related to production moved outside Israel and recorded no provision, stating an unfavorable outcome was considered less than 50% probable. Certain grant terms also restrict transfers of technology and manufacturing outside Israel.
- Business and operating risks: Results are cyclical and depend on capital spending in electronics; about 79% of 2014 revenue came from Asia Pacific. The company also cites competitive pricing, long customer qualification cycles, inventory obsolescence, reliance on limited or sole-source suppliers, currency exposure and the commercialization risk of Gryphon.
- In January 2015, Camtek transferred the Sela division’s remaining activities and liabilities to a buyer, ending its active involvement. The transfer followed a decision to stop further Xact development and prior inventory and asset write-downs.
Most important facts for investors to verify
- Review the appeal status and potential financial impact of the Rudolph judgments, injunction, bond, restricted collateral and subsequent Eagle lawsuit.
- Assess whether improving gross margins and semiconductor AOI growth can continue, and whether the PCB segment can return to profitability.
- Monitor Gryphon customer qualifications, commercial orders and realized revenue; the filing provides no quantified adoption outlook.
- Reconcile the increase in inventory with sales and cash generation, including the $1.5 million classified as long-term inventory and the company’s assumptions about future use.
- Confirm liquidity after the $7.9 million restricted deposit and evaluate the OCS dispute and continuing grant-related obligations.